Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?
Giovanni TarantinoVincenzo CitroPublished in: International journal of molecular sciences (2024)
Nonalcoholic fatty liver disease, recently re-named metabolic dysfunction-associated steatotic fatty liver disease, is considered the most prevalent liver disease worldwide. Its molecular initiation events are multiple and not always well-defined, comprising insulin resistance, chronic low-grade inflammation, gut dysbiosis, and mitochondrial dysfunction, all of them acting on genetic and epigenetic grounds. Nowadays, there is a growing public health threat, which is antibiotic excessive use and misuse. This widespread use of antibiotics not only in humans, but also in animals has led to the presence of residues in derived foods, such as milk and dairy products. Furthermore, antibiotics have been used for many decades to control certain bacterial diseases in high-value fruit and vegetables. Recently, it has been emphasised that antibiotic-induced changes in microbial composition reduce microbial diversity and alter the functional attributes of the microbiota. These antibiotic residues impact human gut flora, setting in motion a chain of events that leads straight to various metabolic alterations that can ultimately contribute to the onset and progression of NAFLD.
Keyphrases
- low grade
- public health
- insulin resistance
- microbial community
- oxidative stress
- high grade
- chronic pain
- endothelial cells
- dna methylation
- metabolic syndrome
- gene expression
- type diabetes
- genome wide
- adipose tissue
- weight gain
- high fat diet
- liver fibrosis
- polycystic ovary syndrome
- skeletal muscle
- risk assessment
- high speed
- physical activity
- body mass index
- mass spectrometry
- single molecule